Anticoagulants, including warfarin and heparin, are medications that prevent blood clots and their serious complications, with distinct mechanisms of action and therapeutic uses. Warfarin inhibits vitamin K-dependent clotting factor synthesis, while heparin inactivates thrombin and factor Xa, both requiring careful monitoring for adverse effects such as bleeding. Coagulant drugs, aiding in blood clotting, include vitamin K, clotting factor concentrates, fibrin enhancers, and prothrombin complex concentrates, essential for managing bleeding disorders.